Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel vascular access device known as the Ark. The Ark has been designed to facilitate targeted needle placement and strengthen the vein by serving as a supportive exoskeleton. In addition, the Ark will increase patient comfort, and reduce stress and increase efficiency for caregivers, while benefiting the payer system by decreasing the surgeries necessary to enable long-term vascular access.